| 2024-07-25 | -8.0% | legal | SEC EDGAR | UTMD 8-K: 2.01 and (SEC Filing) |
| 2025-04-09 | -7.0% | news | Seeking Alpha | An Unexpected Side-Effect For Utah Medical Products: Recession-Driven Birthrate Declines |
| 2023-09-26 | +6.0% | news | Seeking Alpha | Utah Medical Products: Long-Term Positives, But Filshie Clip Overhang Can't Be Ignored |
| 2021-10-26 | +5.0% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2025-01-28 | -4.9% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $0.86, revenue of $9.16M |
| 2025-01-28 | -4.9% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2022-02-08 | +4.5% | legal | SEC EDGAR | UTMD 8-K: 8.01 and (SEC Filing) |
| 2025-04-24 | -4.4% | news | Stock Titan | STSS Stock Price, News & Analysis - Stock Titan |
| 2023-07-14 | +4.4% | earnings | Seeking Alpha | Utah Medical Products: Earnings Power, Asset Factors Warrant Further Re-Rating |
| 2026-04-23 | -3.9% | earnings | Associated Press | Utah Medical: Q1 Earnings Snapshot |
| 2026-04-23 | -3.9% | news | ACCESS Newswire | Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026 |
| 2026-04-23 | -3.9% | earnings | Seeking Alpha | Utah Medical Products Non-GAAP EPS of $0.81, revenue of $8.72M |
| 2026-04-23 | -3.9% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | -3.9% | earnings | Stock Titan | Utah Medical lost China sales in Q1, but gross margin rose to 60.6% - Stock Titan |
| 2026-04-23 | -3.9% | earnings | Stock Titan | Double-digit revenue drop but strong margins at Utah Medical (Nasdaq: UTMD) - Stock Titan |
| 2025-05-06 | +3.6% | news | Seeking Alpha | Utah Medical Products declares $0.305 dividend |
| 2026-02-04 | +3.1% | earnings | Zacks | Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y |
| 2026-02-04 | +3.1% | earnings | ACCESS Newswire | Utah Medical Products, Inc. Announces Quarterly Dividend |
| 2026-02-04 | +3.1% | news | Seeking Alpha | Utah Medical Products declares $0.31 dividend |
| 2022-02-02 | -2.9% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2022-04-27 | -2.9% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2023-04-25 | +2.8% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2022-10-25 | +2.7% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2024-01-30 | -2.6% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $1.18, revenue of $12.33M |
| 2024-01-30 | -2.6% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2025-04-17 | +2.4% | news | Seeking Alpha | Despite Some Deterioration, Utah Medical Products Is A Solid Play |
| 2024-04-25 | -2.4% | earnings | Seeking Alpha | Utah Medical Products EPS of $1.10, revenue of $11.3M |
| 2024-04-25 | -2.4% | legal | SEC EDGAR | UTMD 8-K: 2.01 and (SEC Filing) |
| 2025-10-23 | -2.4% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $0.82, revenue of $9.8M |
| 2025-10-23 | -2.4% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2025-07-29 | -2.0% | news | Seeking Alpha | Utah Medical Products declares $0.305 dividend |
| 2025-04-25 | -2.0% | news | Stock Titan | ZTEK Stock Price, News & Analysis - Stock Titan |
| 2022-11-01 | +2.0% | legal | SEC EDGAR | UTMD 8-K: 8.01 and (SEC Filing) |
| 2021-11-02 | +1.9% | legal | SEC EDGAR | UTMD 8-K: 8.01 and (SEC Filing) |
| 2024-12-26 | +1.8% | news | Seeking Alpha | Utah Medical Products: Favorably Skewed Risk/Reward Profile |
| 2024-03-22 | +1.7% | news | Seeking Alpha | Utah Medical Products: An Attractive, But Speculative, Prospect |
| 2025-04-29 | -1.6% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2023-10-31 | -1.5% | news | Seeking Alpha | Utah Medical Products raises dividend by 1.7% to $0.30 |
| 2023-10-31 | -1.5% | legal | SEC EDGAR | UTMD 8-K: 8.01 and (SEC Filing) |
| 2024-02-06 | -1.4% | news | Seeking Alpha | Utah Medical Products declares $0.30 dividend |
| 2023-10-26 | -1.4% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $1.08, revenue of $12.5M |
| 2023-10-26 | -1.4% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2023-01-31 | +1.3% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2024-04-26 | -1.3% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $1.09, revenue of $11.34M |
| 2024-08-02 | +1.3% | news | Seeking Alpha | Utah Medical Products declares $0.30 dividend |
| 2026-04-16 | +1.2% | news | Zacks | Utah Medical Gains 32% in a Year: Should You Buy the Stock? |
| 2026-04-16 | +1.2% | news | Zacks Investment Research | Utah Medical Gains 32% in a Year: Should You Buy the Stock? - Zacks Investment Research |
| 2021-07-22 | -1.0% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-01 | +1.0% | news | Zacks | Top Research Reports for American Express, Intuitive Surgical & Shopify |
| 2025-02-04 | -0.9% | news | Seeking Alpha | Utah Medical Products declares $0.305 dividend |
| 2026-01-29 | +0.9% | earnings | Associated Press Finance | Utah Medical: Q4 Earnings Snapshot |
| 2026-01-29 | +0.9% | news | ACCESS Newswire | UTMD Reports Year 2025 and Fourth Quarter Financial Performance |
| 2026-01-29 | +0.9% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $0.80, revenue of $9.04M |
| 2026-01-29 | +0.9% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2026-02-08 | +0.7% | news | Simply Wall St. | Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31 |
| 2025-04-16 | +0.7% | earnings | Seeking Alpha | Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open |
| 2024-05-07 | -0.7% | news | Seeking Alpha | Utah Medical Products declares $0.30 dividend |
| 2023-08-01 | -0.6% | news | Seeking Alpha | Utah Medical Products declares $0.295 dividend |
| 2025-07-03 | -0.6% | news | Seeking Alpha | Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest |
| 2026-04-02 | -0.5% | analyst | Zacks | The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products |
| 2026-04-02 | -0.5% | news | Stock Titan | [DEF 14A] UTAH MEDICAL PRODUCTS INC Definitive Proxy Statement - Stock Titan |
| 2023-07-25 | -0.3% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $1.15, revenue of $12.87M |
| 2023-07-25 | -0.3% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2024-10-29 | -0.2% | earnings | Seeking Alpha | Utah Medical Products GAAP EPS of $3.09, revenue of $31.74M |
| 2024-10-29 | -0.2% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2024-11-05 | +0.2% | news | Seeking Alpha | Utah Medical Products raises dividend by 1.75 to $0.305 |
| 2024-11-05 | +0.2% | legal | SEC EDGAR | UTMD 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-07-24 | +0.2% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2025-10-06 | -0.1% | analyst | Seeking Alpha | Utah Medical Products: A Prudent Downgrade |
| 2022-07-28 | -0.1% | legal | SEC EDGAR | UTMD 8-K: 2.02 and (SEC Filing) |
| 2025-11-04 | +0.0% | news | Seeking Alpha | Utah Medical Products raises dividend by 1.6% to $0.31 |
| 2025-11-04 | +0.0% | legal | SEC EDGAR | UTMD 8-K: 5.02, 8.01 (SEC Filing) |